期刊文献+

肺癌患者抗凝血酶Ⅲ检测的临床意义 被引量:2

Clinical siginificance of the changes of AT III in the patients with lung cancer
下载PDF
导出
摘要 目的探讨肺癌患者抗凝血酶Ⅲ(AT-Ⅲ)的变化。方法根据发色底物法原理检测本院确诊65例肺癌患者AT-Ⅲ的变化,同时以健康体检者为对照组,对两组AT-Ⅲ的结果进行统计学分析。结果肺癌组AT-Ⅲ明显低于健康对照组,且具有统计学意义。结论肺癌患者体内AT-Ⅲ明显低于健康者,是肺癌患者易形成栓塞的重要原因。 Objective To investigate the changes of AT-Ⅲ in the patients with lung cancer.Methods The value of AT-Ⅲ of 65 patients,whose lung cancers were finally diagnosed in the 81th hospital of PLA,were detected by the principle of coloration while the health as control.And the results were analyzed statistically.Results The value of AT-Ⅲ in the group of lung cancer is lower than that of the health group.Conclusion The decrease of AT-Ⅲ of the patients the lung cancer is an important factor of developing pulmonary embolism.
出处 《检验医学与临床》 CAS 2010年第18期1952-1952,1955,共2页 Laboratory Medicine and Clinic
关键词 抗凝血酶Ⅲ 肺癌 肺栓塞 AT-Ⅲ lung cancer pulmonary embolism
  • 相关文献

参考文献8

二级参考文献41

  • 1王曦照,包承鑫,郝梅姝,陈关珍.急性脑梗塞发病期血浆抗凝血酶III动态变化的观察[J].中华血液学杂志,1994,15(9):477-477. 被引量:2
  • 2张志坚,慕容慎行,林新霖,许国英,陈玉珍,丁露茜,冯亚英.急性脑梗塞病人抗凝血酶Ⅲ抗原及活性变化的观察[J].福建医学院学报,1990,24(1):45-47. 被引量:1
  • 3Edwanls RE, Rickles FR.Thrombosis and cancer.In:Hull R,Pineo GF.Disorders of thrombosis.Philadelphia:Saunders, 1996, 374 -384.
  • 4Ho CH , Chau Wk, Hsu HC,et al.Causes of venous thrombosis in fifty chinese patients .Am J Hematol,2000;63:74.
  • 5Yang MH,Fan FS,Chen PM, et al. Venous gangrene in a patient with adenocarcinoma of the lung .Jpn J Clin Oncol,2000;30: 276.
  • 6Emerson TE. Protection against disseminated intravascular coagulation and death by antithrombin Ⅲ in the Escherichia coli endotoxemia rat. Cric Shock, 1987, 21: 1-13.
  • 7Taylor FB, Emerson TE, Jordan R, et al. Antithrombin Ⅲ prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock, 1988, 26: 227-235.
  • 8Uchiba M, Okajima K, Murakami K. Effects of various doses of antithrombin Ⅲ on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res, 1998, 89: 233-241.
  • 9Schipper HG, Jenkins CSP, Kahl LH, et al. Antithrombin Ⅲ transfusion in disseminated intravascular coagulation. Lancet,1978, 1: 854-856.
  • 10Fourrier F, Chopin C, Huart J, et al. Double-blind, placebo-controlled trial of antithrombin Ⅲ concentrates in septic shock with isseminated intravascular coagulation. Chest, 1993, 104: 882-888.

共引文献149

同被引文献18

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部